Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPIC: Antimicrobial Stewardship for VAP in ICU
NCT05124977Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2022
- Primary completion
- Sep 2025
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: All-cause mortality, treatment failure, or occurrence of new episode of pneumonia at 28 days. Started Sep 2022; status: recruiting.
02
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT05124977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05124977.